AstraZeneca PLC (AZNCF) 은(는) 상장 기업입니다 헬스케어 섹터의 제약 산업에서 운영. 본사 소재지는 Cambridge, 영국. 현재 CEO는 Pascal Claude Roland Soriot.
AZNCF 을(를) 보유 IPO 날짜 2009-02-13, 94,300 명의 정규직 직원, 에 상장 Other OTC, 시가총액 $294.4B.
AstraZeneca PLC is a global biopharmaceutical company headquartered in Cambridge, United Kingdom, specializing in the discovery, development, manufacturing, and commercialization of prescription medicines. The company maintains a diverse portfolio spanning oncology, cardiovascular and metabolic diseases, respiratory and immunology, and rare diseases, with marketed products including Tagrisso, Lynparza, and Imfinzi for cancer; Farxiga and Crestor for heart and metabolic conditions; Symbicort and Fasenra for respiratory care; and Soliris for rare diseases, among many others. AstraZeneca also markets vaccines and treatments for respiratory syncytial virus, influenza, COVID-19, and other therapeutic areas. The company distributes its medicines through a global network of physicians and representatives across Europe, the Americas, Asia, Africa, and Australasia. AstraZeneca maintains strategic collaborations with leading pharmaceutical and biotechnology partners, including Regeneron Pharmaceuticals for obesity treatments and Ionis Pharmaceuticals for antisense therapies in development.
